ClariVest Asset Management’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

ClariVest Asset Management’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-188,773	Closed	-$584K	–	812
2021 Q4	$584K	Sell	188,773 -2,327	-1%	-$7.83K	0.02%	412
2021 Q3	$690K	Sell	191,100 -1,300	-0.7%	-$4.9K	0.02%	381
2021 Q2	$689K	Hold	192,400	–	–	0.02%	374
2021 Q1	$752K	Buy	192,400 +10,800	+6%	+$44.6K	0.03%	334
2020 Q4	$763K	Sell	181,600 -2,600	-1%	-$10K	0.03%	310
2020 Q3	$687K	Sell	184,200 -72,887	-28%	-$310K	0.02%	332
2020 Q2	$1.12M	Sell	257,087 -73,312	-22%	-$329K	0.03%	309
2020 Q1	$1.25M	Sell	330,399 -75,700	-19%	-$372K	0.04%	265
2019 Q4	$2.57M	Sell	406,099 -52,900	-12%	-$311K	0.06%	217
2019 Q3	$1.93M	Buy	458,999 +134,111	+41%	+$573K	0.04%	263
2019 Q2	$1.51M	Sell	324,888 -160,212	-33%	-$746K	0.03%	279
2019 Q1	$2.57M	Buy	+485,100	New	+$2.22M	0.05%	288

Other funds holding BDSI

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

FCMT

Founders Capital Management (Texas) Houston, Texas $231M AUM 61.68% 1-Year Est. Return

ClariVest Asset Management's BDSI Position: Q1 2022 in Review

ClariVest Asset Management sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 188,773 shares — an estimated $584K sold.

ClariVest Asset Management first reported a position in BDSI in Q1 2019 and held it in 12 quarters. The position peaked at $2.57M in Q1 2019. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.

ClariVest Asset Management reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
ClariVest Asset Management sold 188,773 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $584K.
ClariVest Asset Management first reported a position in BioDelivery Sciences International, Inc. in Q1 2019 and held it in 12 quarters.
ClariVest Asset Management's BioDelivery Sciences International, Inc. position peaked at $2.57M in Q1 2019.
2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.

Based on ClariVest Asset Management's 13F filing for Q1 2022, filed 4 May 2022.